Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Pediatrix Medical Group, Inc. (MD) since 2005 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Pediatrix Medical Group, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 893949.
Total stock buying since 2005: $19,890,500.
Total stock sales since 2005: $333,386,299.
Total stock option exercises since 2005: $90,367,220.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 0 | $0 | 103,808 | $1,255,275 | 0 | $0 |
| 2023 | 0 | $0 | 73,077 | $957,272 | 0 | $0 |
| 2022 | 0 | $0 | 179,137 | $4,023,567 | 0 | $0 |
| 2021 | 0 | $0 | 630,273 | $17,818,757 | 95,000 | $1,676,749 |
| 2020 | 0 | $0 | 132,000 | $2,908,189 | 17,690 | $0 |
| 2019 | 500,000 | $10,760,602 | 40,279 | $1,207,422 | 0 | $0 |
| 2018 | 0 | $0 | 81,751 | $3,806,030 | 73,336 | $1,929,506 |
| 2017 | 21,704 | $1,210,844 | 162,757 | $10,259,627 | 92,194 | $2,844,064 |
| 2016 | 2,100 | $139,681 | 98,933 | $6,732,204 | 88,230 | $2,591,072 |
| 2015 | 0 | $0 | 458,285 | $33,614,325 | 156,122 | $2,954,443 |
| 2014 | 0 | $0 | 1,149,915 | $68,541,738 | 1,046,272 | $26,195,183 |
| 2013 | 0 | $0 | 429,378 | $43,442,311 | 469,284 | $9,058,708 |
| 2012 | 0 | $0 | 465,309 | $34,459,084 | 176,696 | $6,470,295 |
| 2011 | 50,000 | $3,276,450 | 312,849 | $21,970,744 | 203,381 | $7,553,739 |
| 2010 | 0 | $0 | 100,818 | $5,928,177 | 47,516 | $1,370,394 |
| 2009 | 163,460 | $4,502,923 | 711,826 | $38,488,308 | 392,277 | $5,859,618 |
| 2008 | 0 | $0 | 0 | $0 | 69,778 | $1,862,102 |
| 2007 | 0 | $0 | 260,852 | $14,955,055 | 271,516 | $7,605,516 |
| 2006 | 0 | $0 | 272,705 | $21,846,177 | 248,665 | $11,771,271 |
| 2005 | 0 | $0 | 13,566 | $1,172,037 | 10,266 | $624,560 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-11 | 0 | $0 | 35,708 | $553,388 | 0 | $0 |
| 2024-08 | 0 | $0 | 68,100 | $701,887 | 0 | $0 |
| 2023-12 | 0 | $0 | 7,884 | $75,613 | 0 | $0 |
| 2023-06 | 0 | $0 | 13,193 | $186,549 | 0 | $0 |
| 2023-05 | 0 | $0 | 52,000 | $695,110 | 0 | $0 |
| 2022-11 | 0 | $0 | 66,498 | $1,027,392 | 0 | $0 |
| 2022-01 | 0 | $0 | 112,639 | $2,996,175 | 0 | $0 |
| 2021-12 | 0 | $0 | 181,779 | $4,947,488 | 0 | $0 |
| 2021-11 | 0 | $0 | 13,800 | $391,994 | 0 | $0 |
| 2021-10 | 0 | $0 | 20,895 | $586,278 | 0 | $0 |
| 2021-09 | 0 | $0 | 10,000 | $318,300 | 0 | $0 |
| 2021-08 | 0 | $0 | 103,799 | $3,618,197 | 95,000 | $1,676,749 |
| 2021-07 | 0 | $0 | 100,000 | $3,031,000 | 0 | $0 |
| 2021-04 | 0 | $0 | 100,000 | $2,560,500 | 0 | $0 |
| 2021-01 | 0 | $0 | 100,000 | $2,365,000 | 0 | $0 |
| 2020-12 | 0 | $0 | 100,000 | $2,301,593 | 0 | $0 |
| 2020-09 | 0 | $0 | 32,000 | $606,596 | 0 | $0 |
| 2020-03 | 0 | $0 | 0 | $0 | 17,690 | $0 |
| 2019-11 | 0 | $0 | 5,000 | $114,405 | 0 | $0 |
| 2019-09 | 0 | $0 | 5,000 | $104,050 | 0 | $0 |
| 2019-08 | 500,000 | $10,760,602 | 0 | $0 | 0 | $0 |
| 2019-03 | 0 | $0 | 26,490 | $850,777 | 0 | $0 |
| 2019-02 | 0 | $0 | 1,289 | $46,690 | 0 | $0 |
| 2019-01 | 0 | $0 | 2,500 | $91,500 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-11-13 | Ordan Mark S | Sale | 27,600 | 15.35 | 423,660 |
| 2024-11-08 | Moore Mary Ann E (EVP, GC, Chief Admin Off & Sec) | Sale | 8,108 | 16.00 | 129,728 |
| 2024-08-30 | Swift James D (Chief Executive Officer) | Sale | 11,100 | 10.79 | 119,768 |
| 2024-08-27 | Linynsky Laura A | Sale | 7,000 | 11.16 | 78,120 |
| 2024-08-12 | Richards C Marc (EVP, Chief Financial Officer) | Sale | 17,438 | 10.08 | 175,775 |
| 2024-08-09 | Richards C Marc (EVP, Chief Financial Officer) | Sale | 32,562 | 10.08 | 328,224 |
| 2023-12-14 | Swift James D (Chief Executive Officer) | Sale | 5,764 | 9.58 | 55,219 |
| 2023-12-14 | Moore Mary Ann E (EVP, General Counsel & Sec) | Sale | 2,120 | 9.62 | 20,394 |
| 2023-06-14 | Swift James D (Chief Executive Officer) | Sale | 13,193 | 14.14 | 186,549 |
| 2023-05-25 | Ordan Mark S (Director) | Sale | 33,000 | 13.26 | 437,580 |
| 2023-05-19 | Weis Shirley A (Director) | Sale | 1,007 | 13.63 | 13,725 |
| 2023-05-18 | Weis Shirley A (Director) | Sale | 17,993 | 13.55 | 243,805 |
| 2022-11-21 | Ordan Mark S (Chief Executive Officer) | Sale | 44,332 | 15.45 | 684,928 |
| 2022-01-11 | Medel Roger Md (Director) | Sale | 40,107 | 26.58 | 1,066,044 |
| 2022-01-10 | Medel Roger Md (Director) | Sale | 59,893 | 26.44 | 1,583,570 |
| 2022-01-05 | Medel Roger Md (Director) | Sale | 12,639 | 27.42 | 346,561 |
| 2021-12-30 | Medel Roger Md (Director) | Sale | 45,397 | 27.19 | 1,234,344 |
| 2021-12-29 | Medel Roger Md (Director) | Sale | 25,000 | 27.28 | 682,000 |
| 2021-12-28 | Medel Roger Md (Director) | Sale | 44,514 | 27.28 | 1,214,341 |
| 2021-12-27 | Medel Roger Md (Director) | Sale | 66,868 | 27.17 | 1,816,803 |
| 2021-11-10 | Hinson Roger Mack (Pres., PDX & OBX Medical Group) | Sale | 8,800 | 28.38 | 249,744 |
| 2021-11-10 | Pepia John C (Principal Accounting Officer) | Sale | 5,000 | 28.45 | 142,250 |
| 2021-10-29 | Pepia John C (Principal Accounting Officer) | Sale | 9,238 | 26.87 | 248,225 |
| 2021-10-28 | Medel Roger Md (Director) | Sale | 10,387 | 29.00 | 301,223 |
| 2021-10-04 | Medel Roger Md (Director) | Sale | 1,270 | 29.00 | 36,830 |
| 2021-09-02 | Pepia John C (Principal Accounting Officer) | Sale | 10,000 | 31.83 | 318,300 |
| 2021-08-30 | Ordan Mark S (Chief Executive Officer) | Sale | 95,000 | 35.09 | 3,333,550 |
| 2021-08-30 | Ordan Mark S (Chief Executive Officer) | Option Ex | 95,000 | 17.65 | 1,676,749 |
| 2021-08-10 | Hinson Roger Mack (Pres., PDX & OBX Medical Group) | Sale | 8,799 | 32.35 | 284,647 |
| 2021-07-01 | Medel Roger Md (Director) | Sale | 100,000 | 30.31 | 3,031,000 |
| 2021-04-01 | Medel Roger Md (Director) | Sale | 100,000 | 25.61 | 2,560,500 |
| 2021-01-04 | Medel Roger Md (Director) | Sale | 100,000 | 23.65 | 2,365,000 |
| 2020-12-10 | Medel Roger Md (Director) | Sale | 33,194 | 23.04 | 764,922 |
| 2020-12-09 | Medel Roger Md (Director) | Sale | 66,806 | 23.00 | 1,536,671 |
| 2020-09-15 | Nikolopoulos Nicholas J (EVP Chf Strategy & Growth Officer) | Sale | 10,000 | 19.02 | 190,180 |
| 2020-09-15 | Andreano Dominic J (EVP, General Counsel and Secy) | Sale | 22,000 | 18.93 | 416,416 |
| 2020-03-01 | Pepia John C (Principal Accounting Officer) | Option Ex | 7,862 | .00 | 0 |
| 2020-03-01 | Andreano Dominic J (EVP, General Counsel and Secy) | Option Ex | 9,828 | .00 | 0 |
| 2019-11-01 | Goldschmidt, Md Pascal J (Director) | Sale | 5,000 | 22.88 | 114,405 |
| 2019-09-03 | Goldschmidt, Md Pascal J (Director) | Sale | 5,000 | 20.81 | 104,050 |
| 2019-08-12 | Fernandez Michael (Director) | Buy | 122,409 | 21.35 | 2,613,676 |
| 2019-08-09 | Fernandez Michael (Director) | Buy | 249,106 | 21.52 | 5,361,757 |
| 2019-08-08 | Fernandez Michael (Director) | Buy | 128,485 | 21.68 | 2,785,169 |
| 2019-03-13 | Goldschmidt, Md Pascal J (Director) | Sale | 3,300 | 30.40 | 100,329 |
| 2019-03-07 | Andreano Dominic J (SVP, General Counsel and Secy) | Sale | 4,608 | 30.16 | 138,986 |
| 2019-03-01 | Clark David A. (Chief Operating Officer) | Sale | 6,452 | 32.90 | 212,264 |
| 2019-03-01 | Calabro Joseph M (President) | Sale | 12,130 | 32.91 | 399,198 |
| 2019-02-20 | Andreano Dominic J (SVP, General Counsel and Secy) | Sale | 1,289 | 36.22 | 46,690 |
| 2019-01-22 | Pepia John C (Principal Accounting Officer) | Sale | 2,500 | 36.60 | 91,500 |
| 2018-08-14 | Pepia John C (Principal Accounting Officer) | Sale | 3,500 | 48.18 | 168,640 |
| 2018-06-12 | Pepia John C (Principal Accounting Officer) | Sale | 6,516 | 46.56 | 303,371 |
| 2018-06-12 | Lopez-blanco Vivian (Chief Financial Officer) | Sale | 13,942 | 46.46 | 647,773 |
| 2018-06-11 | Andreano Dominic J (SVP, General Counsel and Secy) | Sale | 18,000 | 46.95 | 845,064 |
| 2018-06-01 | Clark David A. (Pres. Mednax Natl Med Group) | Sale | 11,607 | 45.15 | 524,090 |
| 2018-06-01 | Calabro Joseph M (President and COO) | Sale | 22,186 | 45.20 | 1,002,740 |
| 2018-05-24 | Andreano Dominic J (SVP, General Counsel and Secy) | Option Ex | 6,000 | 27.71 | 166,290 |
| 2018-05-22 | Pepia John C (Principal Accounting Officer) | Sale | 3,000 | 46.43 | 139,290 |
| 2018-05-22 | Pepia John C (Principal Accounting Officer) | Option Ex | 3,000 | 27.71 | 83,145 |
| 2018-05-21 | Lopez-blanco Vivian (Chief Financial Officer) | Option Ex | 40,000 | 25.14 | 1,005,600 |
| 2018-05-04 | Alvarez Cesar L (Director) | Option Ex | 10,668 | 27.71 | 295,663 |
| 2018-03-19 | Sosa Enrique (Director) | Option Ex | 10,668 | 27.71 | 295,663 |
| 2018-03-13 | Pepia John C (Principal Accounting Officer) | Sale | 3,000 | 58.35 | 175,062 |
| 2018-03-13 | Pepia John C (Principal Accounting Officer) | Option Ex | 3,000 | 27.71 | 83,145 |
| 2017-12-12 | Pepia John C (Principal Accounting Officer) | Sale | 3,000 | 51.58 | 154,740 |
| 2017-12-12 | Pepia John C (Principal Accounting Officer) | Option Ex | 3,000 | 27.71 | 83,145 |
| 2017-11-03 | Alvarez Cesar L (Director) | Sale | 10,668 | 42.59 | 454,371 |
| 2017-11-01 | Alvarez Cesar L (Director) | Option Ex | 10,668 | 32.33 | 344,843 |
| 2017-09-12 | Pepia John C (Principal Accounting Officer) | Sale | 3,000 | 42.85 | 128,550 |
| 2017-09-12 | Pepia John C (Principal Accounting Officer) | Option Ex | 3,000 | 27.71 | 83,145 |
| 2017-06-14 | Goldschmidt, Md Pascal J (Director) | Sale | 1,969 | 57.57 | 113,355 |
| 2017-06-01 | Clark David A. (Pres. Mednax Natl Med Group) | Sale | 10,202 | 54.99 | 561,038 |
| 2017-06-01 | Calabro Joseph M (President and COO) | Sale | 23,327 | 55.00 | 1,282,938 |
| 2017-05-05 | Lopez-blanco Vivian (Chief Financial Officer) | Sale | 7,778 | 55.82 | 434,183 |
| 2017-05-05 | Kadre Manuel (Director) | Buy | 21,704 | 55.79 | 1,210,844 |
| 2017-03-15 | Andreano Dominic J (SVP, General Counsel and Secy) | Sale | 6,517 | 70.84 | 461,644 |
| 2017-02-23 | Sosa Enrique (Director) | Sale | 10,668 | 69.65 | 743,058 |
| 2017-02-23 | Sosa Enrique (Director) | Option Ex | 10,668 | 32.33 | 344,843 |
| 2017-02-17 | Lopez-blanco Vivian (Chief Financial Officer) | Sale | 15,164 | 70.01 | 1,061,601 |
| 2017-02-16 | Pepia John C (Principal Accounting Officer) | Sale | 2,500 | 69.58 | 173,952 |
| 2017-02-16 | Pepia John C (Principal Accounting Officer) | Option Ex | 2,500 | 28.55 | 71,362 |
| 2017-02-16 | Andreano Dominic J (SVP, General Counsel and Secy) | Sale | 6,000 | 69.59 | 417,534 |
| 2017-02-16 | Andreano Dominic J (SVP, General Counsel and Secy) | Option Ex | 6,000 | 28.55 | 171,270 |
| 2017-02-16 | Gabos Paul G (Director) | Sale | 21,336 | 69.63 | 1,485,668 |
| 2017-02-16 | Gabos Paul G (Director) | Option Ex | 21,336 | 30.02 | 640,506 |
| 2017-02-10 | Goldschmidt, Md Pascal J (Director) | Sale | 25,294 | 67.81 | 1,715,312 |
| 2017-02-10 | Goldschmidt, Md Pascal J (Director) | Option Ex | 29,688 | 31.41 | 932,529 |
| 2017-02-09 | Waldemar, Md Carlo A (Director) | Sale | 5,334 | 67.90 | 362,183 |
| 2017-02-09 | Waldemar, Md Carlo A (Director) | Option Ex | 5,334 | 32.33 | 172,421 |
| 2017-01-17 | Lopez-blanco Vivian (Chief Financial Officer) | Sale | 10,000 | 70.95 | 709,500 |
| 2016-12-07 | Goldschmidt, Md Pascal J (Director) | Buy | 2,100 | 66.52 | 139,681 |
| 2016-11-10 | Kadre Manuel (Director) | Option Ex | 78,296 | 28.99 | 2,269,957 |
| 2016-09-14 | Goldschmidt, Md Pascal J (Director) | Sale | 1,500 | 65.02 | 97,522 |
| 2016-09-14 | Goldschmidt, Md Pascal J (Director) | Option Ex | 1,500 | 32.33 | 48,487 |
| 2016-06-13 | Andreano Dominic J (SVP, General Counsel and Secy) | Sale | 3,922 | 68.80 | 269,833 |
| 2016-06-08 | Waldemar, Md Carlo A (Director) | Sale | 5,334 | 70.50 | 376,047 |
| 2016-06-08 | Waldemar, Md Carlo A (Director) | Option Ex | 5,334 | 32.33 | 172,421 |
| 2016-06-07 | Wagner Karl B (President, Eastern Division) | Sale | 27,482 | 68.45 | 1,881,142 |
| 2016-06-01 | Stanley Michael D (President, Clinical Services) | Sale | 14,778 | 67.78 | 1,001,711 |
| 2016-06-01 | Clark David A. (President, Western Division) | Sale | 11,470 | 67.78 | 777,471 |
| 2016-06-01 | Calabro Joseph M (President and COO) | Sale | 28,347 | 67.78 | 1,921,388 |
| 2016-05-16 | Andreano Dominic J (SVP, General Counsel and Secy) | Sale | 3,000 | 68.53 | 205,590 |
| 2016-03-11 | Goldschmidt, Md Pascal J (Director) | Sale | 3,100 | 65.00 | 201,500 |
| 2016-03-11 | Goldschmidt, Md Pascal J (Director) | Option Ex | 3,100 | 32.33 | 100,207 |
| 2015-12-11 | Goldschmidt, Md Pascal J (Director) | Sale | 5,250 | 70.99 | 372,676 |
| 2015-12-11 | Goldschmidt, Md Pascal J (Director) | Option Ex | 5,250 | 32.33 | 169,706 |
| 2015-09-08 | Alvarez Cesar L (Director) | Sale | 10,668 | 81.00 | 864,140 |
| 2015-09-08 | Alvarez Cesar L (Director) | Option Ex | 10,668 | 25.17 | 268,513 |
| 2015-08-27 | Medel Roger Md (Chief Executive Officer) | Sale | 100,000 | 80.27 | 8,027,400 |
| 2015-08-06 | Fernandez Michael (Director) | Option Ex | 58,372 | 28.29 | 1,651,168 |
| 2015-07-31 | Lopez-blanco Vivian (Chief Financial Officer) | Sale | 10,000 | 83.45 | 834,479 |
| 2015-07-31 | Goldschmidt, Md Pascal J (Director) | Sale | 1,500 | 82.36 | 123,533 |
| 2015-07-31 | Goldschmidt, Md Pascal J (Director) | Option Ex | 1,500 | 23.69 | 35,532 |
| 2015-07-28 | Medel Roger Md (Chief Executive Officer) | Option Ex | 43,580 | .00 | 0 |
| 2015-06-08 | Wagner Karl B (Pres, American Anesthesiology) | Sale | 37,820 | 70.28 | 2,657,838 |
| 2015-06-03 | Calabro Joseph M (President and COO) | Sale | 70,153 | 70.52 | 4,947,189 |
| 2015-06-01 | Stanley Michael D (Pres., Pediatrix Medical Group) | Sale | 18,522 | 70.48 | 1,305,430 |
| 2015-06-01 | Clark David A. (COO, Pediatrix Medical Group) | Sale | 14,654 | 70.48 | 1,032,784 |
| 2015-06-01 | Calabro Joseph M (President and COO) | Sale | 37,918 | 70.48 | 2,672,422 |
| 2015-03-09 | Goldschmidt, Md Pascal J (Director) | Sale | 8,500 | 71.25 | 605,659 |
| 2015-03-09 | Goldschmidt, Md Pascal J (Director) | Option Ex | 8,500 | 23.69 | 201,348 |
| 2015-02-26 | Medel Roger Md (Chief Executive Officer) | Sale | 100,000 | 71.61 | 7,161,199 |
| 2015-02-20 | Waldemar, Md Carlo A (Director) | Sale | 10,668 | 71.50 | 762,762 |
| 2015-02-20 | Waldemar, Md Carlo A (Director) | Option Ex | 10,668 | 27.71 | 295,663 |
| 2015-02-06 | Andreano Dominic J (SVP, General Counsel and Secy) | Sale | 3,200 | 70.75 | 226,400 |
| 2015-02-06 | Lopez-blanco Vivian (Chief Financial Officer) | Sale | 8,250 | 69.95 | 577,087 |
| 2015-02-02 | Gabos Paul G (Director) | Sale | 17,584 | 68.07 | 1,196,872 |
| 2015-02-02 | Gabos Paul G (Director) | Option Ex | 17,584 | 18.91 | 332,513 |
| 2015-01-30 | Hawk William C (COO American Anesthesiology) | Sale | 3,598 | 68.50 | 246,455 |
| 2014-11-14 | Medel Roger Md (Chief Executive Officer) | Sale | 51,290 | 62.59 | 3,210,189 |
| 2014-11-14 | Medel Roger Md (Chief Executive Officer) | Option Ex | 51,290 | 27.71 | 1,421,502 |
| 2014-11-13 | Medel Roger Md (Chief Executive Officer) | Sale | 21,428 | 62.56 | 1,340,557 |
| 2014-11-13 | Medel Roger Md (Chief Executive Officer) | Option Ex | 21,428 | 27.71 | 593,877 |
| 2014-11-11 | Medel Roger Md (Chief Executive Officer) | Sale | 42,012 | 62.54 | 2,627,514 |
| 2014-11-11 | Medel Roger Md (Chief Executive Officer) | Option Ex | 42,012 | 27.71 | 1,164,362 |
| 2014-11-07 | Medel Roger Md (Chief Executive Officer) | Sale | 3,585 | 62.51 | 224,105 |
| 2014-11-07 | Medel Roger Md (Chief Executive Officer) | Option Ex | 3,585 | 27.71 | 99,358 |
| 2014-11-06 | Medel Roger Md (Chief Executive Officer) | Sale | 125,248 | 62.60 | 7,840,399 |
| 2014-11-06 | Medel Roger Md (Chief Executive Officer) | Option Ex | 125,248 | 27.71 | 3,471,248 |
| 2014-11-05 | Medel Roger Md (Chief Executive Officer) | Sale | 143,912 | 62.62 | 9,011,049 |
| 2014-11-05 | Medel Roger Md (Chief Executive Officer) | Option Ex | 143,912 | 26.03 | 3,746,029 |
| 2014-11-04 | Medel Roger Md (Chief Executive Officer) | Sale | 15,052 | 62.52 | 940,990 |
| 2014-11-04 | Medel Roger Md (Chief Executive Officer) | Option Ex | 15,052 | 22.35 | 336,412 |
| 2014-11-03 | Medel Roger Md (Chief Executive Officer) | Sale | 10,881 | 62.52 | 680,291 |
| 2014-11-03 | Medel Roger Md (Chief Executive Officer) | Option Ex | 10,881 | 22.35 | 243,190 |
| 2014-10-31 | Medel Roger Md (Chief Executive Officer) | Sale | 25,083 | 62.52 | 1,568,113 |
| 2014-10-31 | Medel Roger Md (Chief Executive Officer) | Option Ex | 25,083 | 22.35 | 560,605 |
| 2014-10-30 | Lopez-blanco Vivian (Chief Financial Officer) | Sale | 8,800 | 60.00 | 528,000 |
| 2014-10-30 | Wagner Karl B (Pres, American Anesthesiology) | Sale | 40,000 | 62.50 | 2,500,000 |
| 2014-10-30 | Wagner Karl B (Pres, American Anesthesiology) | Option Ex | 40,000 | 27.71 | 1,108,600 |
| 2014-10-30 | Medel Roger Md (Chief Executive Officer) | Sale | 36,509 | 62.63 | 2,286,558 |
Insider trading activities including stock purchases, stock sales, and option exercises of MD listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Pediatrix Medical Group, Inc. (symbol MD, CIK number 893949) see the Securities and Exchange Commission (SEC) website.